Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 10 studies | 27% ± 11% | |
endothelial cell | 10 studies | 25% ± 10% | |
glutamatergic neuron | 9 studies | 43% ± 24% | |
epithelial cell | 8 studies | 34% ± 17% | |
type II pneumocyte | 8 studies | 29% ± 11% | |
GABAergic neuron | 7 studies | 40% ± 20% | |
club cell | 6 studies | 29% ± 9% | |
ciliated cell | 5 studies | 26% ± 8% | |
fibroblast | 5 studies | 21% ± 6% | |
astrocyte | 5 studies | 29% ± 10% | |
oligodendrocyte precursor cell | 5 studies | 27% ± 10% | |
interneuron | 5 studies | 40% ± 22% | |
neuron | 4 studies | 28% ± 7% | |
basal cell | 4 studies | 39% ± 17% | |
mesothelial cell | 4 studies | 26% ± 7% | |
goblet cell | 4 studies | 33% ± 22% | |
oligodendrocyte | 4 studies | 24% ± 8% | |
podocyte | 3 studies | 32% ± 4% | |
GABAergic interneuron | 3 studies | 21% ± 6% | |
granule cell | 3 studies | 22% ± 6% | |
microglial cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2692.93 | 1445 / 1445 | 100% | 79.13 | 183 / 183 |
lung | 100% | 2363.36 | 578 / 578 | 100% | 58.04 | 1155 / 1155 |
ovary | 100% | 2781.55 | 180 / 180 | 100% | 128.92 | 430 / 430 |
prostate | 100% | 2625.48 | 245 / 245 | 100% | 44.56 | 500 / 502 |
uterus | 100% | 2391.65 | 170 / 170 | 99% | 52.63 | 456 / 459 |
breast | 100% | 1852.40 | 459 / 459 | 99% | 36.91 | 1110 / 1118 |
thymus | 100% | 3786.73 | 653 / 653 | 98% | 42.43 | 595 / 605 |
bladder | 100% | 2279.76 | 21 / 21 | 98% | 33.93 | 492 / 504 |
stomach | 100% | 2609.45 | 359 / 359 | 97% | 50.27 | 278 / 286 |
brain | 99% | 1723.61 | 2623 / 2642 | 98% | 17.94 | 690 / 705 |
intestine | 100% | 1903.49 | 966 / 966 | 97% | 35.60 | 511 / 527 |
pancreas | 97% | 869.20 | 318 / 328 | 98% | 37.68 | 174 / 178 |
kidney | 100% | 2060.84 | 89 / 89 | 94% | 23.80 | 846 / 901 |
skin | 100% | 2650.09 | 1808 / 1809 | 78% | 14.64 | 369 / 472 |
adrenal gland | 100% | 1181.48 | 258 / 258 | 57% | 6.70 | 132 / 230 |
liver | 95% | 602.46 | 214 / 226 | 47% | 6.94 | 191 / 406 |
spleen | 100% | 999.74 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 53.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.43 | 1 / 1 |
blood vessel | 100% | 2001.25 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1821.76 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 1039.57 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 1074.35 | 818 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 8.07 | 16 / 29 |
peripheral blood | 42% | 398.88 | 390 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 1.22 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0062197 | Biological process | cellular response to chemical stress |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0060252 | Biological process | positive regulation of glial cell proliferation |
GO_0061024 | Biological process | membrane organization |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0099072 | Biological process | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO_0045216 | Biological process | cell-cell junction organization |
GO_0035089 | Biological process | establishment of apical/basal cell polarity |
GO_0042462 | Biological process | eye photoreceptor cell development |
GO_0046903 | Biological process | secretion |
GO_0045197 | Biological process | establishment or maintenance of epithelial cell apical/basal polarity |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0048194 | Biological process | Golgi vesicle budding |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0007015 | Biological process | actin filament organization |
GO_0034351 | Biological process | negative regulation of glial cell apoptotic process |
GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
GO_0006468 | Biological process | protein phosphorylation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_2000353 | Biological process | positive regulation of endothelial cell apoptotic process |
GO_0016477 | Biological process | cell migration |
GO_0005903 | Cellular component | brush border |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0070160 | Cellular component | tight junction |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031252 | Cellular component | cell leading edge |
GO_0045171 | Cellular component | intercellular bridge |
GO_0043220 | Cellular component | Schmidt-Lanterman incisure |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0120157 | Cellular component | PAR polarity complex |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0005768 | Cellular component | endosome |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005543 | Molecular function | phospholipid binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004697 | Molecular function | diacylglycerol-dependent serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRKCI |
Protein name | Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) Protein kinase C iota type (EC 2.7.11.13) (nPKC-iota) |
Synonyms | DXS1179E |
Description | FUNCTION: Calcium- and diacylglycerol-independent serine/ threonine-protein kinase that plays a general protective role against apoptotic stimuli, is involved in NF-kappa-B activation, cell survival, differentiation and polarity, and contributes to the regulation of microtubule dynamics in the early secretory pathway. Is necessary for BCR-ABL oncogene-mediated resistance to apoptotic drug in leukemia cells, protecting leukemia cells against drug-induced apoptosis. In cultured neurons, prevents amyloid beta protein-induced apoptosis by interrupting cell death process at a very early step. In glioblastoma cells, may function downstream of phosphatidylinositol 3-kinase (PI(3)K) and PDPK1 in the promotion of cell survival by phosphorylating and inhibiting the pro-apoptotic factor BAD. Can form a protein complex in non-small cell lung cancer (NSCLC) cells with PARD6A and ECT2 and regulate ECT2 oncogenic activity by phosphorylation, which in turn promotes transformed growth and invasion. In response to nerve growth factor (NGF), acts downstream of SRC to phosphorylate and activate IRAK1, allowing the subsequent activation of NF-kappa-B and neuronal cell survival. Functions in the organization of the apical domain in epithelial cells by phosphorylating EZR. This step is crucial for activation and normal distribution of EZR at the early stages of intestinal epithelial cell differentiation. Forms a protein complex with LLGL1 and PARD6B independently of PARD3 to regulate epithelial cell polarity. Plays a role in microtubule dynamics in the early secretory pathway through interaction with RAB2A and GAPDH and recruitment to vesicular tubular clusters (VTCs). In human coronary artery endothelial cells (HCAEC), is activated by saturated fatty acids and mediates lipid-induced apoptosis. Involved in early synaptic long term potentiation phase in CA1 hippocampal cells and short term memory formation (By similarity). . |
Accessions | P41743 B5BUK7 ENST00000295797.5 |